Blue Haven RX review

The flat-dose promise here is exactly what you want if your plan is to stay small: same price at every dose, no increases, with a complete list of what the figure covers — consultation, prescription, medication and shipping in one number. Then the page disagrees with itself. The two product cards and the FAQ further down give different prices for both molecules, and not by a rounding error: the number the FAQ gives for semaglutide is the number the cards give for tirzepatide, and the FAQ's tirzepatide figure appears nowhere else on the site. A third figure, attached to a three-month start, sits between the two. Nothing says which is current, which is promotional, or which one you will actually be charged. Underneath all three sits a detail that changes every one of them. The month being priced is four weeks of medication, stated inside the inclusion list rather than in a footnote, and thirteen four-week periods fit into a year. So whichever figure turns out to be the real one costs roughly nine per cent more over twelve months than its face value suggests. Ask which price applies before starting, and ask it in writing.

Vs median

$20/mo below the $169 median across the 242 of 373 programs we track that publish a plain monthly rate

Market

$59–$1300/mo is the full published spread in our ranking

Structure

Same price at every dose

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Flat at every dose

Price last updated

August 2026

Blue Haven RX does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

The flat-dose promise here is exactly what a low-dose reader is looking for, and the inclusion list is unusually complete — consultation, prescription, medication and shipping in one figure, with no price increase as the dose rises. Then the page disagrees with itself. The two product cards and the FAQ give different prices for both molecules, and not by a rounding error: the number the FAQ gives for semaglutide is the number the cards give for tirzepatide, and the FAQ's tirzepatide figure appears nowhere else. A third figure, attached to a three-month start, sits between the two. Nothing on the page says which is current, which is promotional or which one a reader will actually be charged. Underneath all three sits a detail that changes every one of them: the month being priced is four weeks of medication, stated inside the inclusion list rather than in a footnote. Thirteen four-week periods fit in a year, so whichever figure turns out to be the real one costs roughly nine per cent more over twelve months than its face value suggests.

The product cards and the FAQ give different prices for both molecules, on the same page.

• A month is four weeks, so every figure is thirteen charges a year rather than twelve.
• No milligram is published, so the flat-dose promise cannot be checked against a quantity.

Blue Haven RX is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What microdosing GLP-1 costs
• Low dose vs full dose
• The true annual cost of a plan
• What a flat price costs at a low dose